Beta-blockers in patients with septic shock: plenty of promise, but no hard evidence yet

被引:1
作者
Kim, Won-Young [1 ]
Hong, Sang-Bum [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
DYSFUNCTION; INHIBITION; SEPSIS;
D O I
10.21037/jtd.2016.08.52
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:E1041 / E1043
页数:3
相关论文
共 33 条
  • [1] Beta-blockers in septic shock: A review
    Vela-Vasquez, R. S.
    Grigorov-Tzenkov, I.
    Aguilar, J. L.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2015, 62 (02): : 90 - 95
  • [2] Beta-blockers in septic shock to optimize hemodynamics? Yes
    Reuter, Daniel A.
    Russell, James A.
    Dessap, Armand Mekontso
    INTENSIVE CARE MEDICINE, 2016, 42 (10) : 1607 - 1609
  • [3] Glucose–insulin–potassium infusion in sepsis and septic shock: no hard evidence yet
    Iwan CC van der Horst
    Jack JM Ligtenberg
    Henk JG Bilo
    Felix Zijlstra
    Rijk OB Gans
    Critical Care, 7
  • [4] Beta-Blockers in Cirrhosis Patients With Refractory Ascites
    Robins, Anne
    Bowden, Anne
    Watson, William
    Smith, Fiona
    Gelson, William
    Griffiths, William
    HEPATOLOGY, 2014, 59 (05) : 2054 - 2055
  • [5] Classification of patients with septic shock: Are we there yet?
    Wittebole, Xavier
    Scicluna, Brendon P.
    JOURNAL OF CRITICAL CARE, 2018, 47 : 320 - 321
  • [6] Heart Failure Complicated by Atrial Fibrillation Don't Bury the Beta-Blockers Just Yet
    Piccini, Jonathan P.
    Allen, Larry A.
    JACC-HEART FAILURE, 2017, 5 (02) : 107 - 109
  • [7] The concomitant use of ultra short beta-blockers with vasopressors and inotropes in critically ill patients with septic shock: A systematic review and meta-analysis of randomized controlled trials
    Al Sulaiman, Khalid
    Alkofide, Hadeel A.
    AlFaifi, Mashael E.
    Aljohani, Sarah S.
    Al Harthi, Abdullah F.
    Alqahtani, Rahaf A.
    Alanazi, Ashwaq M.
    Nazer, Lama H.
    Al Shaya, Abdulrahman I.
    Aljuhani, Ohoud
    SAUDI PHARMACEUTICAL JOURNAL, 2024, 32 (06)
  • [8] Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
    Nabilou, Puria
    Danielsen, Karen Vagner
    Kimer, Nina
    Hove, Jens Dahlgaard
    Bendtsen, Flemming
    Moller, Soren
    PLOS ONE, 2022, 17 (06):
  • [9] Association Between Premorbid Beta-Blocker Exposure and Sepsis Outcomes-The Beta-Blockers in European and Australian/American Septic Patients (BEAST) Study
    Tan, Kaiquan
    Harazim, Martin
    Simpson, Andrew
    Tan, Yi Chern
    Gunawan, Gunawan
    Robledo, Kristy P.
    Whitehead, Christina
    Tang, Benjamin
    Mclean, Anthony
    Nalos, Marek
    CRITICAL CARE MEDICINE, 2021, 49 (09) : 1493 - 1503
  • [10] Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
    Lee, Heirim
    Song, Jinyoung
    Kang, I-Seok
    Huh, June
    Yoon, Jin A.
    Shin, Yong Beom
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2022, 65 (10) : 507 - 509